on Gastrointestinal Imaging:

Criteria its developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.

[1]  J. Ward,et al.  American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease , 2021, Hepatology (Baltimore, Md.).

[2]  A. Zaheer,et al.  ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. , 2020, Journal of the American College of Radiology : JACR.

[3]  Stephanie R. Wilson,et al.  Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma , 2019, Abdominal Radiology.

[4]  Kathryn J Fowler,et al.  Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS) , 2019, Journal of magnetic resonance imaging : JMRI.

[5]  Yu Shen,et al.  Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[7]  Yi Dong,et al.  Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings , 2018, BioMed research international.

[8]  M. Huang,et al.  Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma following Transarterial Chemoembolization: Is It Helpful for Tumor Response? , 2018, BioMed research international.

[9]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[10]  E. Tapper,et al.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study , 2018, British Medical Journal.

[11]  M. Mazurowski,et al.  Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. , 2018, AJR. American journal of roentgenology.

[12]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[13]  C. Sirlin,et al.  Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis , 2018, Hepatology.

[14]  Robert M. Marks,et al.  Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. , 2017, Clinical radiology.

[15]  Wen-Pei Wu,et al.  Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma. , 2017, Ultrasound in medicine & biology.

[16]  Zixing Huang,et al.  Gadoxetic acid disodium–enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta‐analysis , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  J. Marrero,et al.  Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US. , 2017, The American journal of medicine.

[18]  M. Kudo,et al.  Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update , 2017, Hepatology International.

[19]  Seth T. Lirette,et al.  Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death. , 2017, Radiology.

[20]  P. Pickhardt,et al.  Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. , 2016, AJR. American journal of roentgenology.

[21]  S. Baik,et al.  Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis , 2016, Gut and liver.

[22]  T. Murakami,et al.  Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe , 2015, Liver Cancer.

[23]  Mohammad Hassan Murad,et al.  Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  Robert M. Marks,et al.  Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. , 2015, AJR. American journal of roentgenology.

[25]  M. Ronot,et al.  Imaging of benign hepatocellular lesions: current concepts and recent updates. , 2014, Clinics and research in hepatology and gastroenterology.

[26]  Jin-Young Choi,et al.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. , 2014, Radiology.

[27]  D. Marin,et al.  Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. , 2014, Radiology.

[28]  Benjamin M Yeh,et al.  Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. , 2013, AJR. American journal of roentgenology.

[29]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[30]  B. Choi,et al.  Comparison of Magnetic Resonance Elastography and Gadoxetate Disodium–Enhanced Magnetic Resonance Imaging for the Evaluation of Hepatic Fibrosis , 2013, Investigative radiology.

[31]  M. Yoshikawa,et al.  Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. , 2013, Magnetic resonance imaging.

[32]  P. Zhou,et al.  Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity. , 2013, Hepatobiliary & pancreatic diseases international : HBPD INT.

[33]  Bryce D. Smith,et al.  Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma , 2013, Annals of Internal Medicine.

[34]  R. Ehman,et al.  Magnetic resonance elastography of liver: Technique, analysis, and clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.

[35]  M. C. Chammas,et al.  Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. , 2013, Ultrasound in medicine & biology.

[36]  S. Ahn,et al.  Characterization of focal liver masses using acoustic radiation force impulse elastography. , 2013, World journal of gastroenterology.

[37]  I. Kamel,et al.  An Elevated Arterial Enhancement Fraction Is Associated With Clinical and Imaging Indices of Liver Fibrosis and Cirrhosis , 2012, Journal of computer assisted tomography.

[38]  Alton B Farris,et al.  Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium‐enhanced 3D gradient echo imaging , 2012, Journal of magnetic resonance imaging : JMRI.

[39]  Hui Zhu,et al.  Performance of magnetic resonance elastography and diffusion‐weighted imaging for the staging of hepatic fibrosis: A meta‐analysis , 2012, Hepatology.

[40]  Myeong-Jin Kim,et al.  Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. , 2012, The British journal of radiology.

[41]  S. Kumano,et al.  Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT , 2012, Journal of Gastroenterology.

[42]  R. Pozzi Mucelli,et al.  Acoustic Radiation Force Impulse (ARFI) ultrasound imaging of solid focal liver lesions. , 2012, European journal of radiology.

[43]  Kuni Ohtomo,et al.  Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. , 2011, European journal of radiology.

[44]  Noriyuki Moriyama,et al.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. , 2011, Radiology.

[45]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[46]  D. Lu,et al.  CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  M. Kudo Real Practice of Hepatocellular Carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress , 2010, Oncology.

[48]  Giovanni Vizzini,et al.  Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants , 2010, European Radiology.

[49]  T. Kim,et al.  Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. , 2009, European journal of radiology.

[50]  J. Bruix,et al.  Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star. , 2009, Gastroenterology.

[51]  Yun Yen,et al.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[52]  Gunda Millonig,et al.  Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis , 2008, Hepatology.

[53]  G. Fattovich,et al.  Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and α-fetoprotein levels , 2008, La radiologia medica.

[54]  Ze-Zhou Song Acute viral hepatitis increases liver stiffness values measured by transient elastography , 2008, Hepatology.

[55]  M. Hashizume,et al.  Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications , 2008, Journal of gastroenterology and hepatology.

[56]  J. Bruix,et al.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.

[57]  K. Jhaveri,et al.  Value of the Unenhanced Phase for Detection of Hepatocellular Carcinomas 3 cm or Less When Performing Multiphase Computed Tomography in Patients With Cirrhosis , 2007, Journal of computer assisted tomography.

[58]  Sheng-Nan Lu,et al.  Small hepatic nodules (≤2 cm) in cirrhosis patients: characterization with contrast‐enhanced ultrasonography , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[59]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[60]  P. Roderick,et al.  Performance of serum marker panels for liver fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.

[61]  S. Paggi,et al.  Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C. , 2005, World journal of gastroenterology.

[62]  L. Oğuzkurt,et al.  Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. , 2005, European journal of radiology.

[63]  H. Hussain,et al.  Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially‐enhancing liver mass , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[64]  Carlo Catalano,et al.  Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. , 2005, Radiology.

[65]  D. Mitchell,et al.  Right posterior hepatic notch sign: A simple diagnostic MR finding of cirrhosis , 2003, Journal of magnetic resonance imaging : JMRI.

[66]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[67]  Hisham Tchelepi,et al.  Sonography of Diffuse Liver Disease , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[68]  M. Laeeq Khan,et al.  Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.

[69]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[70]  L. Beretta,et al.  Cirrhosis: diagnosis with sonographic study of the liver surface. , 1989, Radiology.

[71]  W. Alexander,et al.  European Association for the Study of the Liver , 1968 .

[72]  Claude B. Sirlin,et al.  Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid , 2016, Abdominal Radiology.

[73]  Benjamin M Yeh,et al.  Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. , 2013, Radiology.

[74]  V. Mazzaferro,et al.  EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .

[75]  J. Kao,et al.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients , 2011, European Radiology.

[76]  D. Harnois,et al.  Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .

[77]  Steven Solga,et al.  Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? , 2009, Journal of hepatology.

[78]  Irccs Ospedale Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C , 2005 .

[79]  V. Šimonovský The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. , 1999, The British journal of radiology.

[80]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[81]  Anru Zhang,et al.  [A prospective study of early detection for primary liver cancer]. , 1996, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[82]  M. Bernardino,et al.  Computed tomography of hepatic morphologic changes in cirrhosis of the liver. , 1986, Journal of computer assisted tomography.